Barinthus – Talk Bio

Barinthus Biotherapeutics Announces Reverse Merger with Clywedog Therapeutics to Form New Metabolic Disease-Focused Company

4 weeks ago talkbio0Tagged Autoimmune Diseases, Barinthus, biotherapeutics, Board Composition, Clywedog Therapeutics, Delaware merger, lock-up, Menstruation, Metabolic Diseases, reverse merger, Scheme of Arrangement, Shareholder Ownership Structure, Topco, UK

Barinthus Biotherapeutics; Reverse Merger; Clywedog Therapeutics; Metabolic Diseases; Autoimmune Diseases; Topco; Shareholder Ownership Structure; UK Scheme of Arrangement; Delaware Merger; Self-Tender Offer; Lock-Up Period; Board Composition

Barinthus’ HPV Therapy Demonstrates Safety Yet Falls Short in Efficacy

2 years ago talkbio0Tagged Barinthus, Clinical Trials, Effectiveness, Homo sapiens, HPV therapy, Safety, vaccine alternatives

Barinthus, HPV therapy, safety, efficacy, clinical trials, human papillomavirus, vaccine alternatives

Barinthus Bio’s HPV Immunotherapy Fails to Demonstrate Statistically Significant Efficacy in Early Study

2 years ago talkbio0Tagged Barinthus, Bio, Effectiveness, HPV immunotherapy, underwhelming, VTP-200

Barinthus Bio, HPV immunotherapy, VTP-200, early study, underwhelming results, efficacy